Clinical trial
Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer
NCT00102375 · AGO Study Group, Other · Completed
Key facts
| NCT number | NCT00102375 |
|---|---|
| Title | Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer |
| Official title | Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan |
| Lead sponsor | AGO Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Topotecan |
| Enrollment | 900 |
| Start date | Dec 1, 1999 |
| Completion | Oct 1, 2004 |
| First posted | Jan 31, 2005 |
| Last update posted | Aug 4, 2006 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: